Gateshead & South Tyneside LPC  
  • Home
  • News Stream
  • Services
    • Winter Access Services
    • Tackle High BP
    • Microspirometry
    • 2019-20 South Tyneside Council Flu Service
    • 2019-20 Gateshead Council Flu Service
    • GP2P Service
    • CPRS
    • NHS Health Checks - Gateshead
    • NHS Health Checks - South Tyneside
    • Think Pharmacy First Gateshead
    • Think Pharmacy First ST
    • EHC-South Tyneside
    • EHC-Gateshead
  • PCN
    • PCN Comms
  • Maintenance
    • Meetings
    • Flu Service 2013-14 >
      • Regional LPC Flu WebSite
      • Flu Training
      • Latest Flu Communications
      • Flu Resources
      • Marketing Material
      • Vaccine Code
  • Events
  • Search
  • Contact Us
  • 03 - Declaration of Interest
  • LPC Members
    • Mail
    • LPC Forums
    • Old Members Site
  • Archive - Vaccination Site Staffing
  • New Page
  • Covid Workfore Survey
  • News Video
  • C19-CareHome-Resident Vacs
  • Vaccination Site Staffing

Pregabalin (Lyrica) — licensing differences between Lyrica and generic products

29/1/2015

0 Comments

 
Picture
You will be aware that pregabalin (Lyrica) patent is changing and generic pregabalin is becoming available.  The NPA have issued the advice below regarding the licencing of the product.

The NPA have also informed us that are also in the process of discussing this issue with the MHRA and Pfizer.



Dear Pharmacist

You may find in the coming months that generic pregabalin is available to order. I would like to highlight to you that although the patent for pregabalin expired in July 2014, this patent expiry related to the use of pregabalin in epilepsy and generalised anxiety disorder; Pfizer will retain a patent for the use of pregabalin in the treatment of peripheral and central neuropathic pain in adults until July 2017.

This means that until July 2017, generic manufacturers of pregabalin will only be able to obtain a licence for pregabalin for use in epilepsy and/or generalised anxiety disorder and Lyrica, Pfizer’s branded product, will remain the only product licensed for use in pain as well as epilepsy and generalised anxiety disorder.

Pfizer has indicated that it will contest any challenges to the patent for pain.

To avoid any possible patent infringement by pharmacists, steps will need to be taken to ensure that where generic pregablin is requested on a prescription the correctly licensed product is supplied. This may mean contacting the prescriber and establishing the indication and requesting that the prescription is amended and ordered by brand as Lyrica if necessary.

Although generic pregabalin is unlikely to differ clinically from the branded Lyrica, supplying the generic version of pregabalin for neuropathic pain may have the following implications for pharmacists:

  • Generic pregabalin preparations will not include information relating to neuropathic pain in the patient information leaflet and pharmacists will be supplying a product off-licence
  • Supplying generic pregabalin for neuropathic pain would not be in line with Medicines and Healthcare products Regulatory Agency’s risk hierarchy guidance for the supply of unlicensed medicinal products, which states that a UK-licensed product should always be supplied for the correct licensed indication
  • Using generic pregabalin for neuropathic pain may be deemed by Pfizer to be a patent infringement by all parties concerned, including the prescriber and the supplying pharmacist
Currently, reimbursement for NHS prescriptions for pregabalin is based on Lyrica. This may change when generic versions become available meaning that pharmacists may not be correctly reimbursed where Lyrica is supplied against a generically written prescription for pregabalin.  I advise that where generic prescriptions for pregabalin are received, the prescriber is contacted to ascertain the indication. Where the indication is for neuropathic pain, the prescription should be returned to the prescriber for amendment to Lyrica. Prescriptions for pregabilin for epilepsy or generalised anxiety disorder can be dispensed with either Lyrica or appropriately licensed generic versions. 

When supplying pregabalin for the treatment of epilepsy, pharmacists should also consider MHRA guidance issued in 2013 regarding the generic prescribing of antiepileptics. The guidance states that pregabalin does not generally need to be prescribed by brand for the treatment of epilepsy unless there are specific concerns such as patient anxiety and a risk of confusion or dosing errors.

For further information on this or any other query please contact the NPA Pharmacy Services Team on 01727 891 800 / 08447 364 201 or email pharmacyservices@npa.co.uk .
Kind regards,
Leyla
Leyla Hannbeck Msc, MRPharmS
Head of Pharmacy Services

Tel: 01727 858 687 ext 3372 Mobile: 07508932868
Email: l.hannbeck@npa.co.uk 






0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    News Stream

    This is our News Stream.  Any News stories that appear on our website will be archived here for your convenience in Chronological Order with Catogery  tags to help you find items you are looking for.   

    You can also use our search bar  to find items and our RSS feed on this page to keep informed of news. 

    RSS Feed


    LPC Newsletter Archive

    Copies of our older Paper Based News Letters (The LPC News) can be found by clicking below.

    Picture
    LPC News Letter Archive

    Archives

    July 2022
    June 2022
    May 2022
    March 2022
    January 2022
    September 2021
    August 2021
    July 2021
    June 2021
    April 2021
    March 2021
    January 2021
    December 2020
    October 2020
    September 2020
    August 2020
    February 2020
    January 2020
    December 2019
    October 2019
    July 2019
    March 2019
    February 2019
    January 2019
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    March 2018
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012

    Categories

    All
    Action
    Alert
    Announcement
    Business
    Call To Action
    Campaign
    Category M
    Cd's
    Christmas
    Commisioning
    Concessions
    Consultation
    Contractual
    Controlled Drugs
    Council
    Cpaf
    Cpd
    Delivery
    Diabetes
    Drug Tariff
    Ehc
    Election
    Essential Services
    Event
    Finance
    First Contact Clinical
    Flu
    Funding
    Future
    Gateshead
    Gphc
    Guidance
    Health Checks
    Healthy Living Pharmacy
    HMRC
    Hope Winch
    Info
    Information Governance Ig
    INR
    Inspection
    IT
    Lecture
    Legislation
    Local Policy
    Lpn
    Lrc
    Medicines-management
    Meeting
    Mental Capacity Act
    Mental Health
    Mhra
    Mur
    Needle Exchange
    Nhs
    Nhs Contacts
    NHS Mail
    Nms
    North East Pharmacy Forum
    Palliative Care
    Payments
    Pharmacy Qualifications
    Politics
    Pre - Reg
    Prescription Charge
    Psnc
    Public Health
    Reacll
    Recall
    Resources
    RPS
    RPS Event
    Services
    Sexual Health
    Shared Care
    Smoking Cessation
    Standards
    Structure
    Students
    Substance Misuse
    Sunderland Uni
    Tax
    Training
    Up To Date
    Urgent Care
    Vaping

    RSS Feed

Gateshead & South Tyneside Local Pharmaceutical Committee 2016


Photos used under Creative Commons from USCPSC, GovInslee, NHSE, weisserstier, mjtmail (tiggy), RambergMediaImages, Brett Jordan